Share this article

Professor
Simon Fishel, Care Facility managing director, said the study was remarkable for a number of reasons.

'It's blood thinning treatment - it's a drug called heparin - possibly even aspirin, but we're studying that at the moment.

'Those
women who have had very poor prognosis . . . Can now have the chance of a
live birth similar to people who don't have this problem.'

The gene variant, called C4/M2, creates difficulties for the embryo implanting in the womb. And remarkably, it can be passed on through both men or women.

'We studied
our IVF patients and found that 44 per cent of couples carried the
gene,' Prof Fishel said. 'This is the first time in the world where it has been found that a
man can carry a gene that can pass on miscarriage to a woman.'